Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Media
    • Podcast
    • Video
    • Education
  • About
    • Conference Proceedings
    • Vacancies

Tag: Abrocitinib

JAK inhibitors for AD in the real world

Presented By
Dr Yik Weng, National Skin Centre, Singapore
Conference
WCD 2023

31 August, 2023 18:02

Eligibility and selection of JAK inhibitors for constitutional eczema

Presented By
Dr Dirk Jan Hijnen, Erasmus MC, the Netherlands
Conference
DDD 2023

10 May, 2023 13:57

Therapies for atopic dermatitis: still moving forward

Presented By
Prof. Christian Vestergaard, Aarhus University Hospital, Denmark
Conference
SPIN 2022

26 August, 2022 10:58

Monitoring is key during JAK inhibitor therapy

Presented By
Prof. Jonathan Silverberg
Conference
AAD 2022

17 May, 2022 10:47

Abrocitinib demonstrates fast itch control and skin clearance in atopic dermatitis

Presented By
Prof. Kristian Reich, University Medical Center Hamburg-Eppendorf, Germany
Trial
Phase 3, JADE DARE
Conference
EADV 2021

18 November, 2021 13:26

Good response and pruritus reduction in AD with novel selective JAK1 inhibitor

Presented By
Dr Melinda Gooderham
Trial
JADE MONO-2
Conference
AAD 2020

6 August, 2020 07:08

Green light for a second JAK inhibitor in AD

Presented By
Prof. Eric Simpson, Oregon Health & Science University, USA
Trial
Phase 3, JADE MONO-1
Conference
EADV 2019

9 December, 2019 14:06

Can JAK inhibitors close the current therapeutic gap in AD?

Presented By
Prof. Eric Simpson, Oregon Health & Science University, USA
Conference
AAD 2019

19 April, 2019 14:12
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy